These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 20012018

  • 1. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
    Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G.
    Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, Scialla JJ, de Boer IH, Leonard MB, Feldman HI, Wolf M, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [Abstract] [Full Text] [Related]

  • 3. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [Abstract] [Full Text] [Related]

  • 4. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH.
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [Abstract] [Full Text] [Related]

  • 5. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW, Hung PH, Hsiao CY, Liou HH, Lin HS, Huang TH, Jou IM, Tsai KJ.
    PLoS One; 2015 Apr; 10(7):e0133278. PubMed ID: 26186634
    [Abstract] [Full Text] [Related]

  • 6. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moysés RMA.
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [Abstract] [Full Text] [Related]

  • 7. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N.
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [Abstract] [Full Text] [Related]

  • 8. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z.
    Eur J Med Res; 2018 Apr 17; 23(1):18. PubMed ID: 29665846
    [Abstract] [Full Text] [Related]

  • 9. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y, Zhang H, Li Y, Li Q, Zuo L.
    Bone; 2014 Jan 17; 58():168-76. PubMed ID: 24145307
    [Abstract] [Full Text] [Related]

  • 10. Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?
    Figurek A, Spasovski G.
    Int Urol Nephrol; 2018 Oct 17; 50(10):1863-1870. PubMed ID: 30030677
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of fibroblast growth factor-23 in children with chronic kidney disease.
    Magnusson P, Hansson S, Swolin-Eide D.
    Scand J Clin Lab Invest; 2010 Feb 17; 70(1):15-20. PubMed ID: 19929273
    [Abstract] [Full Text] [Related]

  • 12. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H, Kuro-O M, Ishikawa SE, Funazaki S, Kusaka I, Kakei M, Hara K.
    Nephrology (Carlton); 2018 Mar 17; 23(3):226-230. PubMed ID: 28052525
    [Abstract] [Full Text] [Related]

  • 13. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.
    Malhotra R, Katz R, Hoofnagle A, Bostom A, Rifkin DE, Mcbride R, Probstfield J, Block G, Ix JH.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):36-44. PubMed ID: 29208626
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
    Fidan N, Inci A, Coban M, Ulman C, Kursat S.
    J Investig Med; 2016 Apr 06; 64(4):861-6. PubMed ID: 26969749
    [Abstract] [Full Text] [Related]

  • 15. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kim CS, Bae EH, Ma SK, Han SH, Lee KB, Lee J, Oh KH, Chae DW, Kim SW, KNOW-CKD Study Group.
    J Korean Med Sci; 2017 Feb 06; 32(2):240-248. PubMed ID: 28049234
    [Abstract] [Full Text] [Related]

  • 16. The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
    Diniz H, Frazão JM.
    Nefrologia; 2013 Nov 13; 33(6):835-44. PubMed ID: 24158124
    [Abstract] [Full Text] [Related]

  • 17. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D'Haese PC, Evenepoel P.
    PLoS One; 2017 Nov 13; 12(5):e0176411. PubMed ID: 28493902
    [Abstract] [Full Text] [Related]

  • 18. GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
    Canney M, Djurdjev O, Tang M, Zierold C, Blocki F, Wolf M, Levin A.
    Am J Nephrol; 2019 Nov 13; 50(2):105-114. PubMed ID: 31238301
    [Abstract] [Full Text] [Related]

  • 19. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A, Ureña-Torres P, Zillikens MC, Bover J, Cohen-Solal M.
    Kidney Int; 2017 Dec 13; 92(6):1343-1355. PubMed ID: 28964571
    [Abstract] [Full Text] [Related]

  • 20. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Nov 13; 45(5):949-55. PubMed ID: 19631779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.